SVShruthi Vasanthaiah

Shruthi Vasanthaiah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shruthi Vasanthaiah has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    IMPACT OF CENTRALIZED NIKSHAY ON TB NOTIFICATION AND DATA COMPLETENESS IN INDIGENOUS TRIBES: A 21-YEAR STUDY

    by Mona Rastogi, Aishwarya S. Babu, R Abhishek, Shruthi Vasanthaiah, Parthasarathy Ponnusamy, N Nagarathna, M Rajesh, Deepak Murthy, Akhilesh Pandey, Kumar Gavali Suryanarayana, et al.

    BACKGROUND: Indigenous tribes face a disproportionately high tuberculosis (TB) burden due to deep-rooted socioeconomic disadvantage, highlighting the need for strengthened surveillance and control strategies. METHODS: We conducted a 21-year retrospective study (2005-2025) among tribal and neighboring non-tribal populations attending a tribal-serving hospital in Karnataka. Pre-Nikshay data were transcribed from paper registers, and post-Nikshay data were obtained from the digital system. We assessed negative binomial interrupted time-series regression model, data completeness, TB risk factors, and used multivariable logistic regression to identify determinants of poor treatment outcomes and household contact screening yield. RESULTS: We analyzed 1,512 TB cases (tribal = 1,021; non-tribal = 491). TB detection increased significantly over time, with a steeper rise among tribal populations (pp p =0.029) was independently associated with poor treatment outcome. Among 503 index cases, 1,535 household contacts were identified and 1,161 (75.6%) screened; coverage was lower among tribal contacts (69.8% vs 87.2%; p<0.001). CONCLUSIONS: Nikshay strengthened TB surveillance and improved assessment of TB burden and risk factors in tribal communities.

  • Open Access

    Genomic insights into extrapulmonary tuberculosis reveal enrichment of lineage 2 with high drug resistance in specific clinical phenotypes

    by Kusum Sharma, Aravind Bhandari, Gowrang Kasaba Manjunath, Mona Rastogi, Aishwarya S. Babu, Parthasarathy Ponnusamy, Shruthi Vasanthaiah, Karthick Vasudevan, Priyanka Yadav, John George, et al.

    Background: Certain M. tuberculosis lineages may preferentially infect extrapulmonary sites, potentially influencing clinical outcomes. Poor drug penetration at these sites may cause treatment failure, even in the absence of resistance. Timely access to resistance profiles and lineage information may support more effective, personalized treatment for extrapulmonary tuberculosis (EPTB). Methods: We sequenced 117 M. tuberculosis culture isolates from seven EPTB sites at PGIMER, India. This included cerebrospinal fluid (CSF, n = 40), pus (n = 35), fine-needle aspiration cytology (FNAC, n = 22), tissue (n = 8), ileocaecal biopsy (n = 6), synovial fluid (n = 5), and vitreous fluid (n = 1). Phenotypic drug susceptibility testing (pDST) against 12 drugs was performed using the MYCOTBI sensititre assay. Whole genome sequencing (WGS) on Illumina XTen platform and analyzed using in-house pipelines. Results: Drug resistance was identified in 23.9% (28/117) of isolates by pDST and 29.9% (35/117) by WGS, with 93.0% concordance. WGS detected additional resistant cases missed by MYCOTBI (p = 0.039). Resistance was significantly associated with sample type (p = 0.0446), highest in CSF (16/40, 40.0%). Lineage 2 had the highest resistance (13/24, 54.1%), primarily from CSF (9/13, 69.2%). Mixed infections were observed in 6.8% (8/117) of isolates, mostly involving lineages 2 and 3. Heteroresistance was more common in mixed infections (p = 0.0139). Conclusions: WGS reliably detected resistance to anti-TB drugs, along with lineage and mixed infections. This approach can be applied in culture-free targeted sequencing for rapid detection of resistance and lineage, enabling personalized treatment regimens and improved outcomes in EPTB.